# Dexamethasone Regimens for Prophylaxis of Paclitaxel-associated Hypersensitivity Reaction

> **NCT02349763** · PHASE3 · COMPLETED · sponsor: **Department of Medical Services Ministry of Public Health of Thailand** · enrollment: 260 (actual)

## Conditions studied

- Hypersensitivity Reaction

## Interventions

- **DRUG:** Intravenous Dexamethasone
- **DRUG:** Oral Dexamethasone

## Key facts

- **NCT ID:** NCT02349763
- **Lead sponsor:** Department of Medical Services Ministry of Public Health of Thailand
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02-28
- **Primary completion:** 2015-07-30
- **Final completion:** 2015-08-30
- **Target enrollment:** 260 (ACTUAL)
- **Last updated:** 2020-10-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02349763

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02349763, "Dexamethasone Regimens for Prophylaxis of Paclitaxel-associated Hypersensitivity Reaction". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02349763. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*